Acepodia
Phase 1Acepodia® is developing innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $147M
About
Acepodia® is developing innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
Cell & Gene Therapy
Funding History
2Total raised:$147M
Series B$100MJul 15, 2023
Series A$47MJun 15, 2021